the U.S. Food and Drug Administration (FDA), they began to review the human gene therapy program, and formulated a series of rules and regulations pointing out that gene therapy is only applicable to somatic cells, not germ cells - officially putting gene therapy on the national research ...
gene therapygenetic vectorsclinical trialsdrug-delivery systemsProstate Cancer and Prostatic Diseases, covering all aspects of prostatic diseases, in particular prostate cancer. The journal is of interest to surgeons, oncologists, clinicians, and researchers involved in disease of the prostate....
In our Technology Quarterly this week // we report on a renaissance in neuroscience,withmany drug companies, some of them big ones,showingrenewed interest in the field. with修饰renaissance,表示在这一次复兴中有许多制药公...
Narrative Therapy: The Social Construction of Preferred Realities Michael White says, 'NARRATIVE THERAPY is a wonderful how-to-do-it book that I highly recommend. Why? Because Jill Freedman and Gene Combs have managed to ... J Freedman,G Combs - 《Psyccritiques》 被引量: 1247发表: 1996年 ...
A new gene therapy for sickle cell disease has been deemed safe by a U.S. Food and Drug Administration advisory panel, paving the way for full approval by early December 2023. Ad The FDA had already decided that the therapy, known as exagamglogene autotemcel (exa-cel), was effective....
“Incredible Hulk” Drug Uses Genetic Research to Increase Muscle Growth 15May Bodybuilding Gene Leads to Drug That Inhibits Myostatin In a previousarticle about genetic bodybuildingI mentioned the research behind the potential muscle building properties of the myostatin gene. ...
While caspase-3 is a pro-apoptotic caspase, the cleavage of GSDME by activated caspase-3 after chemotherapy drug treatments provides a cross-talk between the pro-infammatory pryroptosis and anti-inflammatory apoptosis. GSDME expression levels vary in different cell types and tissues. High levels ...
Gene therapy—for so long something that belonged to the future—has just hit the streets. A couple of weeks back, you might have picked up a headline alerting us to the most expensive drug in history—a one off gene therapy cure for spinal muscular atrophy. Novartis have priced the drug...
(ATRA)—a therapy for acute promyelocytic leukemia (APL) that is considered the first example of targeted therapy in cancer, but whose drug target remains elusive—inhibits and degrades active Pin1 selectively in cancer cells by directly binding to the substrate phosphate- and proline-binding ...
a newly identified small molecule suppresses metastasis in mice. These findings suggest that OC2 displaces AR-dependent growth and survival mechanisms in many cases where AR remains expressed, but where its activity is bypassed. OC2 is also a potential drug target in the metastatic phase of ...